2020
DOI: 10.1007/s10517-020-04819-4
|View full text |Cite
|
Sign up to set email alerts
|

Immunotropic Properties of an Experimental Synthetic Selenium-Organic Compound

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

1
2
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
6

Relationship

1
5

Authors

Journals

citations
Cited by 8 publications
(3 citation statements)
references
References 6 publications
1
2
0
Order By: Relevance
“…In addition, significant leukocytopenia was noted by 1 and 3 days after irradiation, while in animals irradiated without selenium subsidies, moderate leukocytosis was recorded by 1 st day, followed by a slight decrease in the absolute number of leukocytes by 3rd day. The described clinical manifestations against the background of increased doses of selenium are consistent with those described in the literature and obtained by us in preclinical studies [7,8].…”
Section: Discussionsupporting
confidence: 88%
“…In addition, significant leukocytopenia was noted by 1 and 3 days after irradiation, while in animals irradiated without selenium subsidies, moderate leukocytosis was recorded by 1 st day, followed by a slight decrease in the absolute number of leukocytes by 3rd day. The described clinical manifestations against the background of increased doses of selenium are consistent with those described in the literature and obtained by us in preclinical studies [7,8].…”
Section: Discussionsupporting
confidence: 88%
“… 9 10 11 12 13 14 NO promotes wound cleaning through the formation of peroxynitrite, deamination of DNA and S-nitrosirovanietiols on the surface of cell membranes, oxidative damage to DNA and lipid peroxidation. 15 16 17 18 19 During the proliferation phase of wound healing, NO increases angiogenesis, and accelerates fibroblast proliferation, maturation and fibrotic transformation of granulation tissue. 15 20 21 22 23 …”
Section: Introductionmentioning
confidence: 99%
“…Earlier, we studied the properties of a new experimental synthetic organoselenium compound 2,6-dipyridinium-9-selenabicyclo[3.3.1]nonane dibromide (974zh) obtained in the Laboratory of Organochalcogen Compounds of A. E. Favorsky Irkutsk Institute of Chemistry. It was found that 974zh suppresses the development of pathological reactions in the organism of experimental animals vaccinated with live tularemia and brucellosis vaccines [5]. It also decreases the cAMP/cGMP ratio in the thymus and spleen of experimental mice, which indirectly reflects proliferative activity of cells of immunocompetent organs.…”
mentioning
confidence: 99%